Announcements
- 2026.07.08 VOLUNTARY ANNOUNCEMENT LuX-Valve Plus Obtained the EU MDR CE Certification
- 2026.07.07 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026
- 2026.06.22 VOLUNTARY ANNOUNCEMENT THE APPROVAL OF KEN-VALVE BY THE HONG KONG DEPARTMENT OF HEALTH HAS BEEN GRANTED
- 2026.06.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
- 2026.05.28 POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING
- 2026.05.21 VOLUNTARY ANNOUNCEMENT THE TWELVE-MONTH CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LuX-Valve Plus EU TRINITY STUDY PRESENTED AT EuroPCR 2026, DEMONSTRATING LARGE SIZE ADVANTAGES WITH PRODUCT
- 2026.05.07 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
- 2026.04.28 PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 28 MAY 2026
- 2026.04.28 NOTICE OF 2025 ANNUAL GENERAL MEETING
- 2026.04.28 2025 Annual Report
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
